A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
Phase 1
Recruiting
- Conditions
- Solid TumoursAdvanced Solid Tumours
- Interventions
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Race Oncology Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT06815575
- Locations
- 🇦🇺
Gosford Hospital, Gosford, New South Wales, Australia
🇦🇺Cancer Care Foundation, Miranda, New South Wales, Australia
🇦🇺Wyong Hospital, Wyong, New South Wales, Australia
A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS
Phase 1
Withdrawn
- Conditions
- Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaHigher Risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
- Interventions
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Race Oncology Ltd
- Registration Number
- NCT05456269
- Locations
- 🇦🇺
Calvary Mater, Newcastle, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath